Silo Pharma, Inc. SILO
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Growth
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Profitability
Each USD of equity lost 75 cents this year.
The 11-year record
EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue $B | 0.0 | 0.0 | 0.0 | 0.0 | ◌ | 0.0 | 0.0 | ◌ | ◌ | ◌ | ◌ |
| Operating income $B | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | ◌ | ◌ |
| EBITDA $B | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ |
| Income tax $B | ◌ | ◌ | ◌ | ◌ | 0.0 | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ |
| Net income $B | −0.0 | −0.0 | −0.0 | −0.0 | 0.0 | −0.0 | −0.0 | −0.0 | 0.0 | −0.0 | −0.0 |
| EPS, diluted $ | −0.50 | −1.19 | −1.20 | ◌ | 0.04 | −0.05 | −0.04 | −0.02 | 0.01 | 0.00 | 0.00 |
| Dividend / sh $ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ |
| Payout % — not applicable: no dividend | — | — | — | — | — | — | — | — | — | — | — |
| ROE % | −74.6 | −78.4 | −44.8 | −40.3 | 75.5 | — | — | −120.4 | 29.6 | — | — |
| Shares out B | 0.01 | 0.00 | 0.00 | 0.00 | 0.10 | 0.09 | 0.02 | 0.02 | 0.05 | 0.03 | 0.03 |
Slide the table for earlier years. "—" not applicable · "◌" not available in our data.
Company facts, as filed
Reconciled in 11 of the 11 fiscal years we could check. 12 checks were skipped: revenue is not tagged before 2019. Eight checks were skipped: the balance sheet is not tagged before 2011. Four checks were skipped: EPS is not tagged before 2011.